Decision time for pancreatic islet-cell transplantation.
Ruggenenti
Piero
P
Mario Negri Institute for Pharmacological Research, Bergamo 24125, Italy.
Remuzzi
Andrea
A
Remuzzi
Giuseppe
G
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007328:Insulin / Q000096:biosynthesis*; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism / Q000637:transplantation*; D051379:Mice; D008822:Mice, Transgenic; D020123:Sirolimus / Q000009:adverse effects; D016559:Tacrolimus / Q000009:adverse effects
D007166:Immunosuppressive Agents; D007328:Insulin; D020123:Sirolimus; D016559:Tacrolimus